Vita Coco COCO insider sales and option holdings detailed in Form 4/A
Rhea-AI Filing Summary
Martin Roper, a director and CEO of Vita Coco Company, Inc. (COCO), amended a Form 4 to report multiple sales of common stock executed pursuant to a Rule 10b5-1 trading plan on September 15–17, 2025. The Form 4/A shows a series of disposals reported as sales (code S) that reduced both direct and indirect beneficial holdings and reports weighted-average prices for the transactions in ranges approximately between $40.00 and $40.54 per share. The filing also discloses several fully vested and unvested non‑qualified stock options exercisable for large blocks of common stock, with exercise prices from $10.178 to $32.78 and various vesting schedules and expiration dates through 2035. The amendment restates the original Form 4 filed September 18, 2025.
Positive
- Sales were executed under a Rule 10b5-1 trading plan, indicating pre-established, documented trading instructions
- Amended Form 4 restates and clarifies prior reporting, improving transparency
- Indirect holdings are identified by named family trusts, providing clearer beneficial ownership structure
Negative
- Insider reported multiple share disposals on September 15–17, 2025, which reduced direct and indirect holdings
- Large outstanding option positions disclosed (aggregate underlying shares across grants), representing potential future share supply
Insights
TL;DR Insider sales were executed under a pre-existing 10b5-1 plan; amendment improves disclosure clarity.
The filing shows that the reporting person used a Rule 10b5-1 trading plan to effect multiple stock sales on September 15–17, 2025, and subsequently amended the original Form 4 to restate those disclosures. From a governance perspective, use of a documented 10b5-1 plan is a compliance best practice because it reduces the appearance of opportunistic timing by insiders. The amendment filing further enhances transparency by clarifying weighted-average price ranges and by identifying shares held indirectly through identified family trusts. Material option holdings and their exercise prices and vesting schedules are fully disclosed, allowing stakeholders to assess potential future selling pressure as options vest.
TL;DR Reported sales and large outstanding options may increase share supply; trades were pre‑planned under 10b5-1.
The Form 4/A documents multiple disposals of common stock (reported as sales) across September 15–17, 2025, at weighted-average prices reported within ranges near $40 per share. The filing lists substantial holdings via non‑qualified stock options with exercise prices as low as $10.178 and as high as $32.78, and aggregate underlying share counts are disclosed per option grant. These details are useful for modeling potential dilution or future insider-driven supply if options are exercised and shares sold. The amendment clarifies earlier reporting and provides buyers and modelers with concrete price ranges and ownership changes to incorporate into short-term liquidity assessments.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 5,000 | $40.217 | $201K |
| Sale | Common Stock | 5,000 | $40.233 | $201K |
| Sale | Common Stock | 5,000 | $40.217 | $201K |
| Sale | Common Stock | 5,000 | $40.225 | $201K |
| Sale | Common Stock | 2,765 | $40.008 | $111K |
| Sale | Common Stock | 2,325 | $40.004 | $93K |
| Sale | Common Stock | 3,216 | $40.006 | $129K |
| Sale | Common Stock | 2,200 | $40.006 | $88K |
| Sale | Common Stock | 5,000 | $40.088 | $200K |
| Sale | Common Stock | 5,000 | $40.091 | $200K |
| Sale | Common Stock | 5,000 | $40.089 | $200K |
| Sale | Common Stock | 5,000 | $40.083 | $200K |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
Footnotes (1)
- The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.32, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.05, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.51, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.33, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.02, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.54, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.32, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.05, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.51, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.29, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.05, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.54, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These shares are held by the Christopher G. Roper Exempt Family Trust. These shares are held by the Peter S. Roper Exempt Family Trust. These shares are held by the Thomas L. Roper Exempt Family Trust. The stock option is fully vested and currently exercisable. The stock option is fully vested and currently exercisable. The stock option vests in four equal annual installments beginning on November 27, 2022. The stock option vests in four equal annual installments beginning on March 10, 2024. The stock option vests in four equal annual installments beginning on March 4, 2025. The stock option vests in four equal annual installments beginning on March 3, 2026.